Drugs / Jianpi Huatan granule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03716063 | Oct 2018 → Dec 2021 | colorectal cancer | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jianpi Huatan granule | “traditional Chinese medicine, including Jianpi Huatan granule (JHG), effectively prevents stage III and high-risk stage II CRC recurrence and metastasis after radical resection...” PMID 36176445 ↗ Sep 2022 |
| Known as | JHG | “traditional Chinese medicine, including Jianpi Huatan granule (JHG), effectively prevents stage III and high-risk stage II CRC recurrence and metastasis after radical resection...” PMID 36176445 ↗ Sep 2022 |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese medicine, including Jianpi Huatan granule (JHG), effectively prevents stage III and high-risk stage II CRC recurrence and metastasis after radical resection...” PMID 36176445 ↗ Sep 2022 |